Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- UCL
- Institute for bioengineering of Catalonia, IBEC
- Nature Careers
- University of Utah
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- Technical University of Cluj-Napoca
- Academic Europe
- Empa
- Leiden University; yesterday published
- Radboud University
- Technical University of Denmark
- The Ohio State University
- The University of Chicago
- Universitat de Barcelona
- University of East Anglia
- University of Nottingham
- Utrecht University
- Ageing better colab
- CIC biomaGUNE
- Center for Biological Research "Margarita Salas"-CSIC
- Charles University
- Charles University, Faculty of Pharmacy in Hradec Kralove
- Crohn’s & Colitis Australia IBD PhD Scholarship
- Delft University of Technology (TU Delft)
- Delft University of Technology (TU Delft); 17 Oct ’25 published
- ETH Zürich
- Ecole Polytechnique Federale de Lausanne - EPFL
- Eindhoven University of Technology (TU/e)
- Faculdade de Ciências e Tecnologia
- Faculdade de Medicina da Universidade do Porto
- Friedrich Schiller University Jena •
- Hebrew University of Jerusalem
- IRB Barcelona
- Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré (IRBLleida)
- KNAW
- KTH Royal Institute of Technology
- Leiden University
- Linköping University
- Multiple
- NORTHUMBRIA UNIVERSITY
- National Renewable Energy Laboratory NREL
- Newcastle University
- Rosalind Franklin Institute
- The Institute of Cancer Research
- The University of British Columbia (UBC)
- The University of Edinburgh
- The University of Manchester;
- UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU
- Universidade de Coimbra
- University Hospital Regensburg
- University of Applied Sciences Northwestern Switzerland
- University of Beira Interior
- University of Birmingham
- University of California
- University of California Davis
- University of Copenhagen
- University of Exeter
- University of Groningen
- University of Hertfordshire
- University of Surrey
- University of Twente (UT)
- Uppsala universitet
- Utrecht University; today published
- Wageningen University and Research Center
- 54 more »
- « less
-
Field
-
PhD studentship in Computational Chemistry – Training force fields for computer-aided drug design with machine learning. Award Summary 100% fees covered, and a minimum tax-free annual living
-
Europe. Through an extensive training program, 10 PhDs will be delivered to the European R&D ecosystem, with expertise in low data ML with domain knowledge in synthetic organic chemistry and drug discovery
-
wall metabolism and membrane integrity Design and synthesise small libraries of peptide analogues Screen compounds against drug-susceptible and drug-resistant clinical isolates Develop combination
-
mechanisms to guide the design and formulation of nanoparticles with superior drug delivery properties. Investigate the interaction between ultrasound, nanoparticles, and biofilms to assess antimicrobial
-
annually, with life-threatening consequences for immunocompromised individuals. With few antifungal drugs available and resistance on the rise, this project explores a novel strategy: engineering the fungal
-
organoids. The insights generated will speed up drug design and development and push forward our understanding of human health and disease. As a Franklin PhD student you will: Work on highly interdisciplinary
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 3 days ago
”, reference HR25-00880, co-funded by “La Caixa Foundation” and by Fundação para a Ciência e Tecnologia, IP. Scientific Area: Drug delivery systems / Nanomedicine 1. Project summary and work plan The aim
-
and develop new PDCs that have potent antitumour activity and are targeted at particular cancers. The PhD student will have and will develop skills in synthesis but will also work at the interface with
-
-molecular binding events. In your PhD project, you will design and study biomolecular aspects of BPM sensors, such as affinity binders and conjugation strategies, in order to determine how these affect the
-
for developing new treatments against drug-resistant infections. Their rapid action and ability to target bacteria in several ways make it difficult for antimicrobial resistance to emerge. Despite this promise